Research Overview: Sermorelin Acetate (GRF 1-29) 5mg
Sermorelin Acetate (GRF 1-29) is a synthetic peptide fragment corresponding to amino acids 1-29 of human growth hormone-releasing hormone, extensively studied for its potential applications in endocrinological research. This highly purified research compound enables scientists to investigate growth hormone regulation mechanisms and neuroendocrine pathways within controlled laboratory settings. As part of our comprehensive Stroid UK Shop, this peptide represents a valuable tool for advancing understanding of hypothalamic-pituitary axis function.
Laboratory Research Applications
Research teams utilise Sermorelin Acetate to examine growth hormone secretion patterns and investigate potential therapeutic applications for growth hormone deficiencies. Studies focus on evaluating its interaction with growth hormone-releasing hormone receptors and subsequent downstream signalling cascades. The compound’s structure allows researchers to analyse the minimum effective sequence required for biological activity, making it particularly valuable for structure-activity relationship studies. Scientists investigating peptide research applications often incorporate this compound into comparative studies with other growth hormone modulators. Additionally, researchers examine its stability profiles and degradation pathways to better understand peptide pharmacokinetics in biological systems.
Technical Specifications
| Parameter | Specification |
|---|---|
| Molecular Formula | C149H246N44O42S |
| Molecular Weight | 3357.9 g/mol |
| Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
| Purity | ≥98% (HPLC) |
| Storage | -20°C, protected from light |
| Solubility | Water soluble |
Our facility maintains strict quality control protocols ensuring consistent peptide integrity. Each batch undergoes comprehensive analytical testing including mass spectrometry and high-performance liquid chromatography. Researchers studying selective androgen receptor modulators often compare peptide-based approaches with small molecule alternatives. The compound’s acetate salt form enhances stability during storage and reconstitution procedures, facilitating reliable experimental outcomes.
Regulatory Compliance
This Sermorelin Acetate preparation is manufactured exclusively for in-vitro research applications and is not intended for human consumption, therapeutic use, or clinical applications. Researchers must ensure proper laboratory protocols and safety measures are implemented when handling this research peptide. All studies should comply with institutional review board guidelines and applicable regulatory frameworks governing peptide research.
